SecSonar.com

Verastem, Inc. (VSTM)

Verastem, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Verastem, Inc. (VSTM) is a Biotechnology company based in US with a market capitalization of $303.9M. Free cash flow was negative at -$137.5M. This page tracks VSTM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 78 employees · IPO Jan 27, 2012

Valuation

Valuation & price

$4.32 · as of May 17, 2026 · -59.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

5.31

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$10.77$7.20$3.62Jul 25Dec 25Jul 26Jul 7, 25$4.69Jul 9, 25$4.81Jul 11, 25$4.68Jul 15, 25$4.89Jul 17, 25$5.11Jul 21, 25$5.10Jul 23, 25$5.35Jul 25, 25$6.14Jul 29, 25$6.29Jul 31, 25$6.17Aug 4, 25$6.01Aug 6, 25$5.72Aug 11, 25$7.70Aug 13, 25$8.02Aug 15, 25$8.22Aug 19, 25$7.79Aug 21, 25$8.63Aug 25, 25$8.98Aug 27, 25$9.29Aug 29, 25$9.25Sep 3, 25$9.50Sep 5, 25$10.77Sep 9, 25$9.92Sep 11, 25$9.35Sep 16, 25$9.13Sep 18, 25$9.54Sep 22, 25$9.13Sep 24, 25$8.61Sep 26, 25$8.89Sep 30, 25$8.83Oct 2, 25$8.99Oct 6, 25$8.61Oct 8, 25$8.94Oct 10, 25$8.57Oct 14, 25$9.00Oct 16, 25$9.51Oct 21, 25$7.99Oct 23, 25$7.81Oct 27, 25$8.72Oct 29, 25$8.80Oct 31, 25$9.45Nov 4, 25$7.91Nov 6, 25$7.93Nov 10, 25$8.25Nov 12, 25$8.51Nov 14, 25$7.56Nov 18, 25$9.27Nov 20, 25$9.81Nov 25, 25$10.25Nov 28, 25$10.64Dec 2, 25$9.78Dec 4, 25$10.60Dec 8, 25$10.25Dec 10, 25$10.01Dec 12, 25$9.61Dec 16, 25$8.64Dec 18, 25$7.75Dec 22, 25$7.90Dec 24, 25$7.87Dec 29, 25$7.76Jan 2, 26$7.23Jan 6, 26$6.88Jan 8, 26$7.87Jan 12, 26$7.11Jan 14, 26$6.79Jan 16, 26$6.68Jan 21, 26$6.36Jan 23, 26$6.38Jan 27, 26$6.50Jan 29, 26$6.41Feb 2, 26$6.25Feb 4, 26$6.79Feb 9, 26$6.65Feb 11, 26$6.34Feb 13, 26$5.82Feb 18, 26$5.71Feb 20, 26$5.93Feb 24, 26$5.90Feb 26, 26$5.72Mar 2, 26$5.82Mar 4, 26$5.81Mar 6, 26$6.38Mar 10, 26$6.39Mar 12, 26$5.84Mar 17, 26$5.67Mar 19, 26$5.82Mar 23, 26$5.39Mar 25, 26$5.09Mar 27, 26$5.04Mar 31, 26$5.30Apr 2, 26$5.63Apr 7, 26$5.45Apr 9, 26$5.59Apr 13, 26$5.66Apr 15, 26$6.33Apr 17, 26$6.58Apr 22, 26$6.07Apr 24, 26$5.91Apr 28, 26$5.46Apr 30, 26$5.46May 4, 26$5.95May 6, 26$6.01May 8, 26$4.89May 12, 26$4.63May 14, 26$4.71May 18, 26$4.26May 20, 26$4.13May 22, 26$4.24May 28, 26$4.29Jun 1, 26$4.19Jun 3, 26$3.62Jun 5, 26$3.71Jun 9, 26$3.82Jun 11, 26$3.94Jun 15, 26$4.00Jun 17, 26$4.17Jun 22, 26$4.25Jun 24, 26$3.85Jun 26, 26$3.78Jul 2, 26$4.50
$3.4552-week range$10.77
Loading valuation history…

Fundamentals

Key fundamentals

$303.9M

Market cap

—

Revenue growth (YoY)

82.9%

Gross margin

-$137.5M

Free cash flow (USD)

-$128.1M

Net debt

Net cash position

94.1%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$0.00FY 2018$26.7MFY 2019$17.5MFY 2020$88.5MFY 2021$2.1MFY 2022$2.6MFY 2023$0.00FY 2024$10.0MFY 2025$30.9M
$0$30.9M

Free cash flow by year

2016 → 2025

FY 2016$-29.5MFY 2017$-57.3MFY 2018$-98.0MFY 2019$-138.5MFY 2020$-33.5MFY 2021$-53.7MFY 2022$-63.7MFY 2023$-86.5MFY 2024$-104.8MFY 2025$-137.5M
-$29.5M-$137.5M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 2024100.0%FY 202582.9%
100.0%82.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

3

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $17KCalkins Daniel · Chief Financial Officer · $17.1KJun 24, 2026Filing
  • Insider sellInsider Sell $87KPaterson Dan · Director, President and CEO · $87.2KJun 24, 2026Filing
  • 8-K eventR&D Update Call ScheduledJun 23, 2026Filing
  • 8-K eventClinical Trial ResultsJun 17, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 26, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventCorporate PresentationMay 7, 2026Filing
  • Insider sellInsider Sell $5KPaterson Dan · Director, President and CEO · $4.7KMay 6, 2026Filing

Questions

Frequently asked questions

What is Verastem, Inc.'s market cap?

Verastem, Inc. (VSTM) has a market capitalization of $303.9M.

What is VSTM's P/E ratio?

A meaningful P/E ratio is not available for VSTM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is VSTM's price-to-book (P/B) ratio?

VSTM trades at 5.31 times book value per share.

Are insiders buying VSTM stock?

SEC Form 4 filings show no open-market insider buys at Verastem, Inc. in the last 90 days (3 sells).

Same arena

Related companies in Biotechnology

AMRN

Amarin Corporation plc

$302.3M

ENTA

Enanta Pharmaceuticals, Inc.

$305.7M

XOMAP

XOMA Corporation

$307M

ARMP

Armata Pharmaceuticals, Inc.

$300.3M

NAGE

Niagen Bioscience Inc

$311.8M

FATE

Fate Therapeutics, Inc.

$317M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.